PMC:7435837 / 14140-14305 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T151","span":{"begin":55,"end":62},"obj":"Body_part"}],"attributes":[{"id":"A151","pred":"fma_id","subj":"T151","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"Reported specific examples include the modification of heparin-like structures against for example dengue and flaviviruses [59], herpes simplex 1 and 2 viruses [60]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T25","span":{"begin":99,"end":105},"obj":"Disease"},{"id":"T26","span":{"begin":129,"end":143},"obj":"Disease"}],"attributes":[{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0005502"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0004609"}],"text":"Reported specific examples include the modification of heparin-like structures against for example dengue and flaviviruses [59], herpes simplex 1 and 2 viruses [60]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T157","span":{"begin":152,"end":159},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Reported specific examples include the modification of heparin-like structures against for example dengue and flaviviruses [59], herpes simplex 1 and 2 viruses [60]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T166","span":{"begin":55,"end":62},"obj":"Chemical"}],"attributes":[{"id":"A166","pred":"chebi_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"Reported specific examples include the modification of heparin-like structures against for example dengue and flaviviruses [59], herpes simplex 1 and 2 viruses [60]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"326","span":{"begin":55,"end":62},"obj":"Chemical"}],"attributes":[{"id":"A326","pred":"tao:has_database_id","subj":"326","obj":"MESH:D006493"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Reported specific examples include the modification of heparin-like structures against for example dengue and flaviviruses [59], herpes simplex 1 and 2 viruses [60]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T107","span":{"begin":0,"end":165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Reported specific examples include the modification of heparin-like structures against for example dengue and flaviviruses [59], herpes simplex 1 and 2 viruses [60]."}

{"project":"2_test","denotations":[{"id":"32731428-16309754-71421297","span":{"begin":124,"end":126},"obj":"16309754"},{"id":"32731428-27604476-71421298","span":{"begin":161,"end":163},"obj":"27604476"}],"text":"Reported specific examples include the modification of heparin-like structures against for example dengue and flaviviruses [59], herpes simplex 1 and 2 viruses [60]."}